Stockscreener 앱 받기
0.2562
11.93%
0.0273
시간 외 거래:
.27
0.0138
+5.39%
전일 마감가:
$0.2289
열려 있는:
$0.24
하루 거래량:
3.13M
Relative Volume:
0.39
시가총액:
$5.54M
수익:
$383.40K
순이익/손실:
$-12.67M
주가수익비율:
-0.1694
EPS:
-1.5126
순현금흐름:
$-10.77M
1주 성능:
-16.82%
1개월 성능:
-4.40%
6개월 성능:
-82.33%
1년 성능:
-84.47%
1일 변동 폭
$0.2235
$0.26
1주일 범위
$0.2235
$0.3074
52주 변동 폭
$0.19
$2.10
Biorestorative Therapies Inc Stock (BRTX) Company Profile
명칭
Biorestorative Therapies Inc
전화
(631) 760-8100
주소
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.2562 | 4.95M | 383.40K | -12.67M | -10.77M | -1.5126 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Biorestorative Therapies Inc 주식(BRTX)의 최신 뉴스
BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease - The Manila Times
Back pain stem cell study to show blinded data from about 45 patients - Stock Titan
Buyout Rumor: Is BioRestorative Therapies Inc backed by strong institutional buying2026 Review & Free High Return Stock Watch Alerts - baoquankhu1.vn
CEO Moves: Is BioRestorative Therapies Inc backed by strong institutional buying2026 Technicals & AI Optimized Trading Strategy Guides - baoquankhu1.vn
BRTX Stock Price, Quote & Chart | BIORESTORATIVE THERAPIES INC (NASDAQ:BRTX) - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
9OF Stock Price and Chart — TRADEGATE:9OF - TradingView
Published on: 2026-03-12 07:13:55 - baoquankhu1.vn
Will BioRestorative Therapies Inc. stock reach all time highs in 20262026 Trading Volume Trends & Technical Entry and Exit Tips - Naître et grandir
What makes BioRestorative Therapies Inc. stock attractive to growth fundsSell Signal & Real-Time Market Sentiment Reports - Naître et grandir
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 2.6% – Should You Sell? - Defense World
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 - Sahm
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 2.6%Should You Sell? - MarketBeat
BioRestorative Therapies, Inc. to Participate in the - GlobeNewswire
BRTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy - GlobeNewswire
BioRestorative eyes early back-pain stem cell use in four US states - Stock Titan
BioRestorative Therapies Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
Aug Breakouts: Whats the beta of BioRestorative Therapies Inc stockJuly 2025 Short Interest & Risk Managed Investment Signals - baoquankhu1.vn
Meme Stocks: Is BioRestorative Therapies Inc a speculative investmentAnalyst Downgrade & Entry Point Confirmation Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs - The Globe and Mail
Biorestorative expands global protection for ThermoStem - marketscreener.com
BioRestorative Therapies Receives Patent Approval for Innovative Brown Adipose-Derived Stem Cell Technology Targeting Obesity and Metabolic Disorders - Quiver Quantitative
Australia clears patent for cell therapy touted as GLP-1 alternative - Stock Titan
BioRestorative (NASDAQ: BRTX) amendment shows no beneficial ownership by filer - Stock Titan
Geopolitics Watch: Whats the beta of BioRestorative Therapies Inc stockTrade Exit Report & Safe Swing Trade Setups - baoquankhu1.vn
What’s the MACD signal for BioRestorative Therapies Inc.2025 Short Interest & Daily Profit Maximizing Tips - mfd.ru
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - MSN
Degenerative Disc Disease Clinical Trial Pipeline Strengthens as 15+ Companies Advance 15+ Regenerative and Non‑Surgical Therapies Toward Market Entry, Finds DelveInsight | Spine BioPharma, Biosplice - Barchart.com
BioRestorative Therapies Raises ~$5 Million in Unit Offering; Issues Five-Year Warrants - TradingView
Auctus discloses 9.9% BioRestorative (BRTX) ownership in Schedule 13G/A - Stock Titan
Will BioRestorative Therapies Inc. stock go up in YEAR2025 Trade Ideas & Verified Stock Trade Ideas - mfd.ru
Aug Levels: Is Antero Midstream Corporation stock showing strong momentum2025 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
BioRestorative Therapies closes $5 million public offering By Investing.com - Investing.com Nigeria
BRTX PE Ratio & Valuation, Is BRTX Overvalued - Intellectia AI
Biorestorative Therapies (NASDAQ:BRTX) Trading 5.9% Higher – Still a Buy? - Defense World
BioRestorative Therapies, Inc. Completes Public Offering Raising Approximately $5.0 Million for Clinical and Research Initiatives - Quiver Quantitative
BRTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
BioRestorative Closes $5 Million Public Offering of 14.3 Million Shares - Intellectia AI
BioRestorative Therapies closes $5 million public offering - Investing.com
BioRestorative Announces Closing of $5.0 Million Public Offering - Bitget
Stem cell firm BioRestorative raises $5M for trials and R&D - Stock Titan
BioRestorative Announces Closing of $5.0 Million Public Offering - GlobeNewswire Inc.
BioRestorative prices $5M stock offering - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Form 424B4 BioRestorative Therapies - StreetInsider
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Published on: 2026-02-12 18:49:00 - mfd.ru
BioRestorative Therapies stock plunges after $5 million public offering By Investing.com - Investing.com Nigeria
Biorestorative Therapies Inc (BRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):